CRYOPORT, INC. Increase (Decrease) in Deferred Revenue
CRYOPORT, INC. (CYRX) reported Increase (Decrease) in Deferred Revenue of -$64.83 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2019-08-09
- CRYOPORT, INC. increase (decrease) in deferred revenue for the quarter ending 2019-06-30 was -$36.43K, a 1117.40% decline year-over-year.
- CRYOPORT, INC. increase (decrease) in deferred revenue for the quarter ending 2019-03-31 was -$28.40K.
- CRYOPORT, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was $3.58K.
- CRYOPORT, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$3.58K.
- CRYOPORT, INC. increase (decrease) in deferred revenue for fiscal 2018 was -$7.13K.
- CRYOPORT, INC. increase (decrease) in deferred revenue for fiscal 2017 was $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|
| 2019-06-30 | -$36.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$64.83K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$28.40K 10-Q · filed 2019-05-09 | ||
| 2018-12-31 | -$7.13K 10-K · filed 2019-03-13 | ||
| 2018-06-30 | $3.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | |
| 2018-03-31 | -$3.58K 10-Q · filed 2019-05-09 | ||
| 2017-12-31 | $0.00 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |